Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A new method using gold nanoshells and infrared light effectively delivers siRNA to cancer and stem cells with precision and minimal damage.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Secretome-based therapies could improve hair growth better than current treatments.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

New and repurposed treatments are improving outcomes in dermatology.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Long-read RNA sequencing can identify complex gene changes in IFAP syndrome.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

New technologies help us understand how the body reacts to medical implants, which can improve implant performance.

Exosome-based therapies may improve skin conditions but need more research for safety and effectiveness.

New treatments targeting specific genes show promise for treating keratin disorders.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Targeting multiple pathways may improve treatments for androgenetic alopecia.